Evidence map›Paper›PMID 37274927›Full record

ArticleAsian journal of pharmaceutical sciences2023

Antibiotic-based small molecular micelles combined with photodynamic therapy for bacterial infections.

Lijiao Yang, Shaomin Song, Meihui Yin, Min Yang, Daoping Yan, Xiaohui Wan, Jipeng Xiao, Yuchen Jiang, Yongchao Yao, Jianbin Luo

Open access · diamondAbstract read
In one paragraph

Article in Asian journal of pharmaceutical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Lijiao YangCollege of Chemistry and Environment, Southwest Minzu University, Chengdu 610041, China.
Shaomin SongCollege of Chemistry and Environment, Southwest Minzu University, Chengdu 610041, China.
Meihui YinCollege of Chemistry and Environment, Southwest Minzu University, Chengdu 610041, China.
Min YangCollege of Chemistry and Environment, Southwest Minzu University, Chengdu 610041, China.
Daoping YanCollege of Chemistry and Environment, Southwest Minzu University, Chengdu 610041, China.
Xiaohui WanCollege of Chemistry and Environment, Southwest Minzu University, Chengdu 610041, China.
Jipeng XiaoCollege of Chemistry and Environment, Southwest Minzu University, Chengdu 610041, China.
Yuchen JiangCollege of Chemistry and Environment, Southwest Minzu University, Chengdu 610041, China.
Yongchao YaoCollege of Chemistry and Environment, Southwest Minzu University, Chengdu 610041, China.
Jianbin LuoCollege of Chemistry and Environment, Southwest Minzu University, Chengdu 610041, China.
Southwest Minzu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The appearance of multidrug-resistant bacteria and the formation of bacterial biofilms have necessitated the development of alternative antimicrobial therapeutics. Antibiotics conjugated with or embedded in nano-drug carriers show a great potential and advantage over free drugs, but the mass proportion of carriers generally exceeds 90% of the nano-drug, resulting in low drug loading and limited therapeutic output. Herein, we fabricated a nanocarrier using antibiotics as the building blocks, minimizing the use of carrier materials, significantly increasing the drug loading content and treatment effect. Firstly, we conjugated betaine carboxylate with ciprofloxacin (CIP) through an ester bond to form the amphiphilic conjugate (CIP-CB), which self-assembled into micelles (CIP-CBMs) in aqueous solutions, with a CIP loading content as high as 65.4% and pH-induced surface charge reversal properties. Secondly, a model photosensitizer (5, 10, 15, 20-tetraphenylporphyrin (TPP)) was encapsulated in CIP-CBMs, generating infection-targeted photodynamic/antibiotic combined nanomedicines (denoted as TPP@CIP-CBMs). Upon accumulation at infection sites or in deep bacterial biofilms, the ester bond between the betaine carboxylate and CIP is cleaved to release free TPP and CIP, leading to a synergetic antibacterial and antibiofilm activity

Indexed as

AntibiofilmAntibiotics based micellesChemo-photodynamic therapyMultidrug-resistantpH responsive

Identifiers

PMID37274927
PMCPMC10236462
OpenAlexW4362582296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.